Exxonmobil Investment Management Inc. TX lowered its holdings in Humana Inc (NYSE:HUM) by 13.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 22,715 shares of the insurance provider’s stock after selling 3,676 shares during the quarter. Exxonmobil Investment Management Inc. TX’s holdings in Humana were worth $5,635,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Koch Industries Inc. purchased a new stake in Humana in the 2nd quarter worth approximately $404,000. Adviser Investments LLC purchased a new stake in Humana in the 3rd quarter worth approximately $635,000. Wells Fargo & Company MN lifted its holdings in Humana by 10.0% in the 3rd quarter. Wells Fargo & Company MN now owns 1,653,318 shares of the insurance provider’s stock worth $402,799,000 after buying an additional 150,173 shares during the period. Commonwealth Bank of Australia lifted its holdings in Humana by 3.9% in the 3rd quarter. Commonwealth Bank of Australia now owns 21,112 shares of the insurance provider’s stock worth $5,138,000 after buying an additional 796 shares during the period. Finally, Icon Advisers Inc. Co. lifted its holdings in Humana by 22.7% in the 3rd quarter. Icon Advisers Inc. Co. now owns 5,400 shares of the insurance provider’s stock worth $1,316,000 after buying an additional 1,000 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Several equities research analysts have weighed in on the company. Goldman Sachs Group assumed coverage on Humana in a report on Wednesday, January 3rd. They issued a “buy” rating and a $305.00 price objective for the company. JPMorgan Chase & Co. cut Humana from an “overweight” rating to a “neutral” rating and set a $253.00 price objective for the company. in a report on Monday, October 9th. ValuEngine cut Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Royal Bank of Canada restated a “hold” rating and issued a $245.00 target price on shares of Humana in a research note on Tuesday, October 10th. Finally, Cowen restated an “outperform” rating and issued a $275.00 target price (up previously from $230.00) on shares of Humana in a research note on Wednesday, September 20th. Eleven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $260.70.

In other Humana news, SVP Brian P. Leclaire sold 1,679 shares of Humana stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the transaction, the senior vice president now owns 9,888 shares in the company, valued at $2,432,151.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jody L. Bilney sold 7,054 shares of Humana stock in a transaction on Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The disclosure for this sale can be found here. Insiders have sold 10,115 shares of company stock valued at $2,501,627 in the last quarter. 0.80% of the stock is owned by company insiders.

Humana Inc (HUM) opened at $263.10 on Thursday. The company has a market capitalization of $37,470.00, a P/E ratio of 20.72, a PEG ratio of 1.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. Humana Inc has a one year low of $186.25 and a one year high of $264.90.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.27 by $0.12. The business had revenue of $13.28 billion during the quarter, compared to analysts’ expectations of $13.41 billion. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.18 earnings per share. analysts expect that Humana Inc will post 11.63 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s payout ratio is 12.60%.

Humana declared that its Board of Directors has initiated a share buyback plan on Thursday, December 14th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the insurance provider to reacquire shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: This piece was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/01/11/humana-inc-hum-shares-sold-by-exxonmobil-investment-management-inc-tx.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.